---
title: "ZyVersa Therapeutics, Inc. (ZVSA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ZVSA.US.md"
symbol: "ZVSA.US"
name: "ZyVersa Therapeutics, Inc."
industry: "生物技術"
---

# ZyVersa Therapeutics, Inc. (ZVSA.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 美股市場 |
| Website | [www.zyversa.com](https://www.zyversa.com) |

## Company Profile

ZyVersa Therapeutics, Inc. 是一家臨床階段的生物制藥公司，專注于開發和商業化用于治療腎臟和炎症疾病的產品。該公司開發了藥物研發平台，包括膽固醇外排介導劑 VAR 200，這是一種可注射藥物，目前正在進行針對腎臟疾病（如局灶性節段性腎小管硬化症、阿爾波特綜合症和糖尿病腎病）的 2a 期臨床試驗；以及炎症小體 ASC 抑制劑 IC 100，這是一種人源化單克隆抗體，目前處于臨床前階段，用于治療包括急性呼吸綜合症、多發性硬化症、胰腺癌、帕金森病和亨廷頓病、動脈粥樣硬化、阿爾茨海默病和肥胖症在內的炎症疾病。該公司與 L&F Research LLC 和 InflamaCORE...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.08 | 81/604 | - | - | - |
| PB | -0.18 | 465/604 | 0.35 | 0.22 | 0.18 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/ZVSA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ZVSA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ZVSA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.